Bassam J Sarrouj, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 4235 Secor Rd, Toledo, OH 43623 Phone: 419-473-3561 |
Jennifer Pelwecki, Internal Medicine - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 2142 N Cove Blvd, Toledo, OH 43606 Phone: 419-291-4000 |
Dr. Jeffrey R Hammersley, M.D. Internal Medicine - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 1000 Regency Ct., Toledo, OH 43623 Phone: 419-720-0317 Fax: 419-720-0319 |
Mrs. Deepa Priya Malaiyandi, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2130 W Central Ave Ste 201, Toledo, OH 43606 Phone: 419-291-3900 Fax: 419-291-0389 |
News Archive
Today, Lung Cancer Alliance (LCA) commended Senator Olympia Snowe (R-ME) and Congresswoman Chellie Pingree (D-ME) for joining Congressman Michael Michaud (D-ME) as cosponsors of the Lung Cancer Mortality Reduction Act (LCMRA), a bi-partisan, bi-cameral bill that establishes the first ever multi-agency, comprehensive research program targeting all aspects of lung cancer.
Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for addiction and obesity, announced today that the Louisiana State University Health Sciences Center (LSUHSC-S) has received a $3.9 million dollar grant from the National Institute on Drug Abuse (NIDA). The grant will support the next stages of development for Embera's drug candidate EMB-001 to treat cocaine dependence, as well as advance EMB-001 into clinical testing.
Insurance needs and health systems vary state to state, and experience tells us that the best way forward is not to mandate a one-size-fits-all answer. Instead, our approach gives states the flexibility to take their own paths, while ensuring they all end up in the best place possible: with an Affordable Insurance Exchange that offers access to comprehensive, quality, affordable health insurance to small business owners and individuals who currently have few good choices in an expensive and broken market.
Scientists have identified a key enzyme responsible for destroying lung tissue in tuberculosis, they report today in the Journal of Clinical Investigation. Drugs that inhibit this enzyme are already available, meaning that the finding could lead quickly to new treatments.
› Verified 5 days ago